Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues        
Total revenues $ 53,286 $ 57,674 $ 94,602 $ 101,380
Cost of sales        
Total cost of sales 47,197 49,277 89,877 94,311
Gross profit 6,089 8,397 4,725 7,069
Operating expenses        
Research and development 21,223 31,370 44,367 55,975
Sales and marketing 10,440 20,406 20,047 40,070
General and administrative 22,944 19,691 41,145 43,573
Goodwill impairment   229,500   229,500
Total operating expenses 54,607 300,967 105,559 369,118
Loss from operations (48,518) (292,570) (100,834) (362,049)
Interest expense (1,109) (633) (1,920) (601)
Interest and other (expense) income, net (78) (5,013) (149) (6,766)
Loss before income taxes (49,705) (298,216) (102,903) (369,416)
Income tax benefit (expense) (23) 944 534 2,200
Net loss $ (49,728) $ (297,272) $ (102,369) $ (367,216)
Net loss per share-Basic $ (0.15) $ (0.95) $ (0.32) $ (1.17)
Net loss per share-Diluted $ (0.15) $ (0.95) $ (0.32) $ (1.17)
Weighted average shares outstanding, basic 321,655,818 313,556,886 320,382,809 312,798,328
Weighted average shares outstanding, diluted 321,655,818 313,556,886 320,382,809 312,798,328
Products        
Revenues        
Total revenues $ 47,398 $ 52,672 $ 84,095 $ 92,148
Cost of sales        
Total cost of sales 43,224 44,913 82,115 86,815
Services        
Revenues        
Total revenues 5,888 5,002 10,507 9,232
Cost of sales        
Total cost of sales $ 3,973 $ 4,364 $ 7,762 $ 7,496